Insider · CIK 0001791857

Jenne Kyle

Reports to the SEC for 2 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001791857

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf GL Pdt Str Ofcr	SSale	−4,902 sh	$75.17	−$368K	23,713
2026-04-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	+12.2K sh	—	—	28,615
2026-04-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	−12.2K sh	—	—	74,402
2026-03-10	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	+32.6K sh	$46.10	+$1.5M	48,991
2026-03-10	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf GL Pdt Str Ofcr	SSale	−21.2K sh	$75.50	−$1.6M	27,800
2026-03-10	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf GL Pdt Str Ofcr	SSale	−16.1K sh	$76.30	−$1.23M	11,714
2026-03-10	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	+4,675 sh	$34.69	+$162K	16,389
2026-03-10	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	−4,675 sh	—	—	14,025
2026-03-10	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	−32.6K sh	—	—	32,601
2026-01-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf GL Pdt Str Ofcr	SSale	−1,823 sh	$75.96	−$138K	16,389
2026-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	+7,013 sh	—	—	18,212
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chf GL Pdt Str Ofcr	AAward	+25.8K sh	—	—	44,500
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chf GL Pdt Str Ofcr	AAward	+9,675 sh	—	—	37,725
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	−7,013 sh	—	—	29,664
2026-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf GL Pdt Str Ofcr	AAward	+19.4K sh	—	—	19,350
2025-04-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf GL Pdt Str Ofcr	SSale	−3,016 sh	$28.36	−$85.5K	11,199
2025-04-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	+12.2K sh	—	—	14,215
2025-04-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf GL Pdt Str Ofcr	MExercise/Conversion	−12.2K sh	—	—	36,677
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chf GL Pdt Str Ofcr	AAward	+18.7K sh	—	—	18,700
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chf GL Pdt Str Ofcr	AAward	+28.1K sh	—	—	28,050
2025-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf GL Pdt Str Ofcr	AAward	+18.7K sh	—	—	18,700
2024-02-26	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf GL Pdt Str Ofcr	AAward	+65.2K sh	—	—	65,203
2020-10-12	AKCEA THERAPEUTICS, INC.U Disposition from Tender	Chief Commercial Officer	UDisposition from Tender	−52K sh	$18.15	−$944K	0
2020-10-12	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−143K sh	$5.94	−$852K	0
2020-10-12	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−32.8K sh	$5.94	−$195K	0
2020-10-12	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−299 sh	$0.77	−$230.23	0
2020-10-12	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−13.7K sh	$0.77	−$10.5K	0
2020-10-12	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−34.2K sh	$5.39	−$184K	0
2020-09-22	AKCEA THERAPEUTICS, INC.S Sale	Chief Commercial Officer	SSale	−720 sh	$18.12	−$13K	52,012
2020-03-23	AKCEA THERAPEUTICS, INC.S Sale	Chief Commercial Officer	SSale	−779 sh	$11.75	−$9,153.484	52,732
2020-03-19	AKCEA THERAPEUTICS, INC.A Award	Chief Commercial Officer	AAward	+16.8K sh	—	—	53,511
2020-03-19	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+34.2K sh	—	—	34,200
2019-10-21	AKCEA THERAPEUTICS, INC.A Award	Chief Commercial Officer	AAward	+25K sh	—	—	36,711
2019-10-21	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Apr 174
Jenne Kyle0000874015-26-000171
SEC(opens sec.gov)
Mar 114
Jenne Kyle0000874015-26-000142
SEC(opens sec.gov)
Jan 204
Jenne Kyle0000874015-26-000066
SEC(opens sec.gov)
Jan 64
Jenne Kyle0000874015-26-000027
SEC(opens sec.gov)
Apr 174
Jenne Kyle0000874015-25-000119
SEC(opens sec.gov)
Jan 174
Jenne Kyle0000874015-25-000061
SEC(opens sec.gov)

Companies

Address

2855 GAZELLE COURT

CARLSBAD, CA, 92010